Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.

Always stay updated with the free CMN Newsletter.

Be Biopharma

Company type: Therapeutics

Main focus: B cell engineering

Company stage: Pre-clinical

Diseases: Cancer

Genome-editing tool: CRISPR

Funding stage: Series B

Location: Cambridge, MA, USA


Pipeline: Not disclosed


Be Biopharma is a pre-clinical-stage company focused on the engineering of B cells via CRISPR, to produce engineered B Cell medicines (BeCMs). Once differentiated in plasma cells ex vivo, BeCMs can be infused into patients and act as cell factories to produce the required therapeutic molecules.

Company: Be Biopharma
Search CRISPR Medicine